Format

Send to

Choose Destination
Leukemia. 2019 Jan 8. doi: 10.1038/s41375-018-0299-2. [Epub ahead of print]

IDH1-R132 changes vary according to NPM1 and other mutations status in AML.

Author information

1
The Institute of Hematology and Research Center for Hemato-Oncological diseases (CREO), University of Perugia, Perugia, Italy. brunangelo.falini@unipg.it.
2
The Institute of Hematology, Ospedale Giovanni XXIII, Bergamo, Italy.
3
The Munich Leukemia Laboratory, Munich, Germany.
4
The Institute of Hematology and Research Center for Hemato-Oncological diseases (CREO), University of Perugia, Perugia, Italy.
5
Pathodiastostik Berlin, Berliner Referenz-und Konsultatios Zentrum fur Lymphoma and Hamatopathologie, Berlin, Germany.
PMID:
30622284
DOI:
10.1038/s41375-018-0299-2

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center